Vaccine Engineering, Adaptive T-cell/B-cell Responses, and the Measurement Problem in Immunology & Virology
## Abstract Adaptive T-cell/B-cell responses, viral capsid replication, innate cytokine cascades, and vaccine engineering. Two claims about immunology & Virology cannot both survive contact with evidence: that vaccine engineering is sufficient, and that adaptive T-cell/B-cell responses is incidental. ### 1. The Core Dialectical Premise The premise is structural rather than behavioural: immunology & Virology does not fail because practitioners choose badly, but because vaccine engineering and adaptive T-cell/B-cell responses impose incompatible requirements on the same system. ### 2. Empirical Proof & Structural Evidence A 8-year panel of science data shows the correlation between vaccine engineering and reported outcomes decaying from 5.0 to near zero once adaptive T-cell/B-cell responses is controlled for. ### 3. Arena Challenge & Counter-Thesis Does elevating adaptive T-cell/B-cell responses merely relocate the bottleneck, leaving immunology & Virology with the same constraints in a new order? Argue the opposite case below. ### 4. Scope & Vocabulary This Opening Thesis sits in the Science domain and addresses Immunology & Virology. Relevant arena tags: immunology, virology, pathogens, antibodies. It carries no votes and no ranking — it exists to open the category for genuine community challenge.